Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
YTHDF2 promotes ATP synthesis and immune evasion in B cell malignancies
Cell ( IF 45.5 ) Pub Date : 2024-12-17 , DOI: 10.1016/j.cell.2024.11.007 Zhenhua Chen, Chengwu Zeng, Lu Yang, Yuan Che, Meiling Chen, Lillian Sau, Bintao Wang, Keren Zhou, Yu Chen, Ying Qing, Chao Shen, Tingjian Zhang, Mark Wunderlich, Dong Wu, Wei Li, Kitty Wang, Keith Leung, Miao Sun, Tingting Tang, Xin He, Jianjun Chen
Cell ( IF 45.5 ) Pub Date : 2024-12-17 , DOI: 10.1016/j.cell.2024.11.007 Zhenhua Chen, Chengwu Zeng, Lu Yang, Yuan Che, Meiling Chen, Lillian Sau, Bintao Wang, Keren Zhou, Yu Chen, Ying Qing, Chao Shen, Tingjian Zhang, Mark Wunderlich, Dong Wu, Wei Li, Kitty Wang, Keith Leung, Miao Sun, Tingting Tang, Xin He, Jianjun Chen
Long-term durable remission in patients with B cell malignancies following chimeric antigen receptor (CAR)-T cell immunotherapy remains unsatisfactory, often due to antigen escape. Malignant B cell transformation and oncogenic growth relies on efficient ATP synthesis, although the underlying mechanisms remain unclear. Here, we report that YTHDF2 facilitates energy supply and antigen escape in B cell malignancies, and its overexpression alone is sufficient to cause B cell transformation and tumorigenesis. Mechanistically, YTHDF2 functions as a dual reader where it stabilizes mRNAs as a 5-methylcytosine (m5C) reader via recruiting PABPC1, thereby enhancing their expression and ATP synthesis. Concomitantly, YTHDF2 also promotes immune evasion by destabilizing other mRNAs as an N6-methyladenosine (m6A) reader. Small-molecule-mediated targeting of YTHDF2 suppresses aggressive B cell malignancies and sensitizes them to CAR-T cell therapy.
中文翻译:
YTHDF2 促进 B 细胞恶性肿瘤中的 ATP 合成和免疫逃逸
嵌合抗原受体 (CAR)-T 细胞免疫治疗后 B 细胞恶性肿瘤患者的长期持久缓解仍然不令人满意,通常是由于抗原逃逸。恶性 B 细胞转化和致癌生长依赖于有效的 ATP 合成,但其潜在机制尚不清楚。在这里,我们报道了 YTHDF2 促进 B 细胞恶性肿瘤中的能量供应和抗原逃逸,仅其过表达就足以引起 B 细胞转化和肿瘤发生。从机制上讲,YTHDF2 起双读取器的作用,它通过募集 PABPC1 将 mRNA 稳定为 5-甲基胞嘧啶 (m 5 C) 读取器,从而增强它们的表达和 ATP 合成。同时,YTHDF2 还通过破坏其他 mRNA 作为 N 6 -甲基腺苷 (m 6 A) 读取器的稳定性来促进免疫逃逸。YTHDF2 的小分子介导靶向抑制侵袭性 B 细胞恶性肿瘤,并使它们对 CAR-T 细胞疗法敏感。
更新日期:2024-12-17
中文翻译:
YTHDF2 促进 B 细胞恶性肿瘤中的 ATP 合成和免疫逃逸
嵌合抗原受体 (CAR)-T 细胞免疫治疗后 B 细胞恶性肿瘤患者的长期持久缓解仍然不令人满意,通常是由于抗原逃逸。恶性 B 细胞转化和致癌生长依赖于有效的 ATP 合成,但其潜在机制尚不清楚。在这里,我们报道了 YTHDF2 促进 B 细胞恶性肿瘤中的能量供应和抗原逃逸,仅其过表达就足以引起 B 细胞转化和肿瘤发生。从机制上讲,YTHDF2 起双读取器的作用,它通过募集 PABPC1 将 mRNA 稳定为 5-甲基胞嘧啶 (m 5 C) 读取器,从而增强它们的表达和 ATP 合成。同时,YTHDF2 还通过破坏其他 mRNA 作为 N 6 -甲基腺苷 (m 6 A) 读取器的稳定性来促进免疫逃逸。YTHDF2 的小分子介导靶向抑制侵袭性 B 细胞恶性肿瘤,并使它们对 CAR-T 细胞疗法敏感。